Efficacious and safe management of type 2 diabetes mellitus using DPP-4 inhibitors
Diabetes mellitus (DM) is believed to be the third most frequent direct cause of death after cardiovascular and oncological diseases. Therefore, solutionof DM-related problems is a major challenge facing health authorities in many countries. No doubt, strict control of glycemia is an indispensableco...
Saved in:
| Main Authors: | Alexander Sergeevich Ametov, Ekaterina Vladimirovna Karpova |
|---|---|
| Format: | article |
| Language: | EN RU |
| Published: |
Endocrinology Research Centre
2010
|
| Subjects: | |
| Online Access: | https://doaj.org/article/79d30283e9ec4221af5b1c7afe77a1d9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Galvus and Galvus Met, new registered medicinal agents for the treatment of diabetes mellitus
by: Editorial team Diabetes Mellitus
Published: (2009) -
Rannyaya kombinirovannaya terapiya pri sakharnom diabete 2 tipa
by: Alexander Sergeevich Ametov, et al.
Published: (2011) -
Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus
by: Editorial team Diabetes Mellitus
Published: (2012) -
Vildagliptin and its role in the treatment of diabetes mellitus
by: Yury Shavkatovich Khalimov
Published: (2010) -
The efficacy of therapy with DPP-4 inhibitors combined with insulin in patients with type 2 diabetes mellitus
by: Alexander Sergeevich Ametov, et al.
Published: (2011)